Identification of a putative structural gene for cathepsin D in Caenorhabditis elegans.

L A Jacobson , L Jen-Jacobson , J M Hawdon , G P Owens
Genetics 119 ( 2) 355 -363

15
1988
PPARγ maintains ERBB2-positive breast cancer stem cells

X Wang , Y Sun , J Wong , D S Conklin
Oncogene 32 ( 49) 5512 -5521

44
2013
COT1, a gene involved in cobalt accumulation in Saccharomyces cerevisiae.

D S Conklin , J A McMaster , M R Culbertson , C Kung
Molecular and Cellular Biology 12 ( 9) 3678 -3688

188
1992
The COT2 gene is required for glucose-dependent divalent cation transport in Saccharomyces cerevisiae.

D S Conklin , C Kung , M R Culbertson
Molecular and Cellular Biology 13 ( 4) 2041 -2049

33
1993
Peroxisome proliferator-activated receptor-γ protects ERBB2-positive breast cancer cells from palmitate toxicity

Antonis Kourtidis , Rekha Srinivasaiah , Richard D Carkner , M Julia Brosnan
Breast Cancer Research 11 ( 2) 1 -11

48
2009
Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer

Leila Kokabee , Xianhui Wang , Christopher J Sevinsky , Wei Lin Winnie Wang
Cancer Biology & Therapy 16 ( 11) 1604 -1615

17
2015
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

Patrick J Paddison , Amy A Caudy , Emily Bernstein , Gregory J Hannon
Genes & Development 16 ( 8) 948 -958

1,681
2002
RNA interference by short hairpin RNAs expressed in vertebrate cells

Gregory J Hannon , Douglas S Conklin
mRNA Processing and Metabolism: Methods and Protocols 255 -266

119
2004
MaRX: An Approach to Genetics in Mammalian Cells

Gregory J Hannon , Peiqing Sun , Amancio Carnero , Lin Ying Xie
Science 283 ( 5405) 1129 -1130

92
1999
Viral vectors and their uses

David H Beach , Gregory J Hannon , Douglas S Conklin , Peiquing Sun

1998
Bruton's tyrosine kinase as anti-cancer drug target

Douglas S Conklin , Cheryl Eifert , Antonis Kourtidis , Xianhui Wang

22
2015
Bruton's tyrosine kinase as anti-cancer drug target

Douglas S Conklin , Cheryl Eifert , Antonis Kourtidis

9
2013
Bruton's tyrosine kinase as anti-cancer drug target

Douglas S Conklin , Cheryl Eifert , Antonis Kourtidis

6
2010
The electronics of HER2/neu positive breast cancer cells

Jan Baumann , Christopher Karch , Antonis Kourtidis , Douglas S Conklin
Breast Cancer Recent Adv Biol Imaging Ther 17 -36

5
2012
Bruton's tyrosine kinase as anti-cancer drug target

Douglas S Conklin , Cheryl Eifert , Antonis Kourtidis , Xianhui Wang

1
2017
Regulators Of Fat Metabolism As Anti-Cancer Targets

Douglas S Conklin , Antonis Kourtidis

1
2010
Bruton's tyrosine kinase as anti-cancer drug target

Douglas S Conklin , Cheryl Eifert , Antonis Kourtidis , Xianhui Wang

2021
Bruton's Tyrosine Kinase as Anti-Cancer Drug Target

Douglas S Conklin , Cheryl Eifert , Antonis Kourtidis , Xianhui Wang

2016
The lipogenic phenotype of HER2/neu-positive breast cancer cells.

Jan M Baumann , Antonis Kourtidis , Douglas S Conklin
Cancer Research 73 ( 8_Supplement) 1894 -1894

2013